Maxwell Biosciences, Inc.

Bee Cave, TX

UEI
EBLFHD7DJKX5
CAGE
8DL13
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Physical address
3809 Juniper Trce #101, Bee Cave, TX 78738, USA
Founded
2016
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

SBA capabilities narrative

Maxwell Bioscience's novel peptoid drug class mimics the natural peptide "LL-37" that plays a key role in the human immune response. Maxwell PeptoidsTM irreversibly inactivate viruses through a novel mechanism of action that is anticipated to deter emergence of drug resistance.

Quick answers

Is Maxwell Biosciences, Inc. registered in SAM.gov?

Yes. Maxwell Biosciences, Inc.'s SAM.gov registration is active through June 10, 2027.

What is Maxwell Biosciences, Inc.'s most recent federal award?

Maxwell Biosciences, Inc.'s most recent federal grant award is Synthetic antimicrobial peptoids for treatment of chronic suppurative otitis media (R41DC020077), from National Institute on Deafness and Other Communincation Disorders (NIH), on September 1, 2021.

On GovTribe

See Maxwell Biosciences, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors